• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quantifying the reduction of primary breast cancer associated with exercise

bySimon PanandAlex Chan
June 16, 2024
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Across a follow-up period of approximately 5 years, there was a non-linear relationship between exercise at breast cancer diagnosis and distant recurrence-free interval (DRFI), with greater exercise exposure up to a certain threshold correlating with greater reductions in the risk of recurrence.

2. The relationship between the level of exercise at diagnosis and DRFI events was only observed in the premenopausal population and not the postmenopausal population.

Evidence Rating Level: 2 (Good)

While studies have shown that exercise both before and after breast cancer (BC) diagnosis is associated with reduced mortality, the association between exercise and disease recurrence after BC diagnosis has not been thoroughly investigated. This multicentre prospective cohort therefore sought to evaluate the relationship between exercise dose and distant recurrence-free interval (DRFI) in BC. Between March 2012 and February 2018, 10,359 patients (mean [SD] age = 56.3 [11.2] years) with stage I-III BC were assessed at baseline and follow-up visits at 1, 2, 4 and 6 years following diagnosis. To account for potential confounding variables that could influence exercise dose at diagnosis, propensity score inverse probability (IPTW) Cox models were used (n = 9,051). Exercise dose was obtained by multiplying the weekly activity session frequency by the average session duration, weighted by the corresponding standardized metabolic equivalent of task (MET) value to yield a total MET-hours per week (MET-h/wk). Across the overall cohort, there was a nonlinear relationship between pre-treatment exercise and DRFI (P = 0.0097), with exercise dose beyond 5 MET-h/wk showing an inverse linear reduction in recurrence risk up to a threshold of 25 MET-h/wk. When comparing an exercise dose of <5 MET-h/wk to an exercise dose of ≥ 5 MET-h/wk in the IPTW population, the adjusted hazard ratio was 0.82 (95% CI = 0.67 to 1.00). Interestingly, this relationship between pre-treatment exercise and DRFI was only observed in the IPTW premenopausal cohort and not the IPTW postmenopausal cohort. Overall, this study found that the relationship between exercise dose at BC diagnosis and risk of DRFI events is nonlinear and further studies investigating the antitumour activity of exercise therapy are warranted. 

Click to read the study in JCO

Image: PD

RELATED REPORTS

Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer

The Scan by 2 Minute Medicine®: Billy Joel’s Brain Condition, Gigi Robinson’s Surgical Advocacy, Climate and Cancer Risk, and West Nile Virus Reaches the United Kingdom

Artificial Intelligence and Real World Data Speed Up Drug Development

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: Breast Cancercancerexerciselifestyle modificationsoncology
Previous Post

Telephone coaching program may help patients achieve weight loss

Next Post

2 Minute Medicine Rewind June 17, 2024

RelatedReports

AI Roundup

Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer

May 28, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Billy Joel’s Brain Condition, Gigi Robinson’s Surgical Advocacy, Climate and Cancer Risk, and West Nile Virus Reaches the United Kingdom

May 27, 2025
AI Roundup

Artificial Intelligence and Real World Data Speed Up Drug Development

May 27, 2025
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Pharma

Drugmakers Increase Prices on Over 250 Medications

May 21, 2025
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

2 Minute Medicine Rewind June 17, 2024

Patient Basics: Large Cell Cancer of the Lung

Osimertinib significantly improved progression-free survival in patients with unresectable stage III non-small cell lung cancer

Differential RNA expression in late onset fetal growth restriction

Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colon Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Personalized visual perceptual learning digital therapy may improve vision post-stroke
  • Delayed alteplase has clinical benefits in posterior circulation stroke outcomes
  • #VisualAbstract: Methotrexate is Noninferior to Prednisone in the Treatment of Pulmonary Sarcoidosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.